Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -3.00 (-2.14%)
Bid:
137.00
Ask:
144.50
Spread: 7.50 (5.474%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Positive half year update

6 Jul 2005 07:00

Xaar PLC06 July 2005 FOR IMMEDIATE RELEASE 6 July 2005 Xaar plc POSITIVE HALF YEAR TRADING UPDATE Xaar plc ("Xaar"), the inkjet printing technology group headquartered inCambridge, presents an update on performance for the six months ended 30 June2005. Results Xaar is pleased to report that revenues for the six months to 30 June 2005 arein line with expectations at close to £20.0m (2004: £16.9m). Profit before tax for the period (and before foreign exchange movements oninter-company loans) is ahead of expectations at around £4.5m (2004: £2.4m on acomparable basis). These figures are stated under UK GAAP to be consistent withcurrent market forecasts. The results reflect a continuing growth in demand for the group's products andthe benefit of increased volumes on manufacturing overhead recovery. Cash at the end of June was in the region of £17.5m, up from £15.4m at the startof the year. This movement includes an increase in working capital and paymentof the final dividend for 2004 of £0.6m. The outlook for the full year continues to be positive. OmniDot Launch The group's OmniDot printhead platform, its new range of products co-developedwith Agfa (and named 'UPH' in its Agfa format), started commercial production inthe second quarter and was officially launched by Agfa at the FESPA tradeshowheld in May in Munich, Germany. FESPA represents the Screen Printing sector of the industry and digital printingaccounted for more than 50% of the stands at the show, with Xaar wellrepresented by its OEMs. Further details of Agfa's revolutionary new digitalinkjet press, the M-Press, and the Anapurna 100 wide format printer can be foundon the Agfa website, www.agfa.com. Announcement of interim results The interim results will be announced in accordance with Xaar's normal timetablein mid-September. The interim results will be prepared under IFRS in accordance with the EUdirective for quoted companies applicable for reporting periods starting on orafter 1 January 2005. The main differences between the two sets of reportingstandards, as they apply to the group, are likely to be in the capitalisation ofcertain research and development costs, the expensing of share option costs andmovements in the valuation of the group's US dollar hedging transactions. Contacts Xaar plc: 01223-423663Ian Dinwoodie, Chief Executive www.xaar.co.ukNigel Berry, Group Finance Director & Deputy Chief Executive Bankside Consultants:Steve Liebmann 020-7367-8883 / 07802-888159 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Sep 20239:57 amRNSHolding(s) in Company
19th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20232:11 pmRNSHolding(s) in Company
11th Sep 202312:14 pmRNSHolding(s) in Company
11th Sep 202312:07 pmRNSHolding(s) in Company
11th Sep 202312:03 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
7th Sep 20239:00 amRNSNotice of 2023 Half Year Results
1st Sep 20239:30 amRNSTotal Voting Rights
25th Aug 202312:13 pmRNSHolding(s) in Company
23rd Aug 202310:24 amRNSHolding(s) in Company
18th Aug 202310:30 amRNSChange of Auditor
17th Aug 202312:55 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSTrading Update
1st Aug 20232:00 pmRNSTotal Voting Rights
28th Jul 20234:30 pmRNSHolding(s) in Company
5th Jul 20239:00 amRNSXaar plc - Commercial partnership with Quantica
4th Jul 20233:00 pmRNSBlock listing Interim Review
3rd Jul 20232:53 pmRNSTotal Voting Rights
1st Jun 202310:37 amRNSTotal Voting Rights
31st May 202311:30 amRNSResult of AGM
31st May 20239:00 amRNSBoard Changes
11th May 20235:41 pmRNSHolding(s) in Company
10th May 20233:10 pmRNSDirector/PDMR Shareholding
2nd May 202312:39 pmRNSTotal Voting Rights
24th Apr 20231:05 pmRNSAnnual Financial Report
3rd Apr 20234:51 pmRNSTotal Voting Rights
28th Mar 20237:00 amRNSFinal Results
20th Mar 20232:00 pmRNSNotification of the 2022 Full Year Results Date
1st Mar 20233:19 pmRNSTotal Voting Rights
20th Feb 202312:35 pmRNSHolding(s) in Company
1st Feb 202312:30 pmRNSTotal Voting Rights
30th Jan 202312:30 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSTrading Update
5th Dec 202210:21 amRNSDirector/PDMR Shareholding
1st Dec 202210:19 amRNSTotal Voting Rights
21st Nov 20224:41 pmRNSSecond Price Monitoring Extn
21st Nov 20224:35 pmRNSPrice Monitoring Extension
3rd Nov 20221:38 pmRNSGrant of Sharesave Options
1st Nov 202210:41 amRNSTotal Voting Rights
13th Oct 20222:20 pmRNSHolding(s) in Company
3rd Oct 20224:07 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNS2022 INTERIM RESULTS
1st Sep 20225:32 pmRNSTotal Voting Rights
30th Aug 202210:26 amRNSNotice of 2022 Half Year Results
1st Aug 20224:33 pmRNSTotal Voting Rights
1st Aug 202211:25 amRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
1st Jul 20221:14 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.